Short description
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
Description
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function. It was founded by a team with deep roots in deubiquitinase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development. The company's proprietary EncompassTM platform was designed to create enhancement-targeting chimeric (ENTACTM) medicines. ENTACs take advantage of DUBs' ability to regulate proteins.
Total funding
$$3123123
Sign in for full access
Location
Watertown, Massachusetts, United States, North America
Founded on
January 1, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$7890 - 12340
Sign in for full access
Investors
Blurry Noaccess, Blurry Noaccess, Cannot Access, Uh Ohhhh, Absolutely Noaccess, Nopepepe, Uh Ohhhh, Cannot Access, Cannot Access
Sign in for full access
Founders
David Komander, David Sheppard, Jarrod Marto, Michael Clague, Sara Buhrlage, Sylvie Urbe, Ueli Nachbur